Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario

SIMPLE SUMMARY: The current study provides data on the efficacy of COVID-19 prime-boost vaccines in 200 patients with hematologic and predominantly lymphoid malignancies as well as a risk-adapted guidance for the management of weak and failed responses to COVID-19 prime-boost vaccination. A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krekeler, Carolin, Reitnauer, Lea, Bacher, Ulrike, Khandanpour, Cyrus, Steger, Leander, Boeckel, Göran Ramin, Klosner, Justine, Tepasse, Phil-Robin, Kemper, Marcel, Hennies, Marc Tim, Mesters, Rolf, Stelljes, Matthias, Schmitz, Norbert, Kerkhoff, Andrea, Schliemann, Christoph, Mikesch, Jan-Henrik, Schmidt, Nicole, Lenz, Georg, Bleckmann, Annalen, Shumilov, Evgenii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688056/
https://www.ncbi.nlm.nih.gov/pubmed/36428605
http://dx.doi.org/10.3390/cancers14225512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688056/
https://www.ncbi.nlm.nih.gov/pubmed/36428605
http://dx.doi.org/10.3390/cancers14225512

Ejemplares similares